Status:
UNKNOWN
Inhaled NO in IPF and COPD During 6 Minute Walk Test
Lead Sponsor:
Rabin Medical Center
Collaborating Sponsors:
Bellerophon
Conditions:
COPD
IPF
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Our objective is to evaluate the influence of inhaled NO on the saturation and exercise capacity of patients with COPD and IPF. each participant will undergo two six minute walk tests, one with inhale...
Detailed Description
This is a randomiized, placebo controlled trail that will evaluate the influence of inhaled NO (INO) on the saturation and exercise capacity of patients with COPD and IPF. All patients will sign a con...
Eligibility Criteria
Inclusion
- Patients with COPD with disease severity of GOLD stage 3-4
- Patients with IPF with a Forced vital capacity under 80% and a diffusion capacity under 60%
- Ambulatory patients that can perform a 6-minute walk test
Exclusion
- Patients with moderate to severe heart failure - EF \< 40%
- Patients with severe PVD or scleroderma
Key Trial Info
Start Date :
March 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03873298
Start Date
March 4 2019
End Date
September 1 2020
Last Update
December 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin Medical Center
Petah Tikva, Israel, 49100